학술논문

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Document Type
Article
Author
Branche, A.R.Falsey, A.R.Walsh, E.E.Walsh, E.Kingsley, P.Steinmetz, K.Peasley, M.Rouphael, N.G.Losada, C.Graciaa, D.S.Samaha, H.Ackerley, C.G.Unterberger, K.E.Diemert, D.J.Malkin, E.Bethony, J.M.Desrosiers, A.Siegel, M.Baden, L.R.Sherman, A.C.Walsh, S.R.Tong, A.Rooks, R.Frey, S.E.Abate, G.Oikonomopoulou, Z.Hoft, D.F.Graham, I.Whitaker, J.A.El Sahly, H.M.Atmar, R.L.Keitel, W.A.Healy, C.M.Little, S.J.Martin, T.C.S.Carter, N.Hendrickx, S.Anderson, E.J.Kamidani, S.Rostad, C.A.Peters, E.Nolan, L.Walter, E.B.Smith, M.J.Eaton, A.Montefiori, D.C.Moody, M.A.Schmader, K.E.Novak, R.M.Ladner, B.G.Wendrow, A.Herrick, J.Rupp, R.Porterfield, L.Jackson, L.A.Dunstan, M.Lau, R.Carste, B.Babu, T.M.Wald, A.Krause, T.Hauge, K.Kottkamp, A.C.Davis, T.Mulligan, M.J.Engelson, C.Soma, V.Luetkemeyer, A.F.Harris, C.Lopez, A.M.Immergluck, L.C.Johnson, E.Chan, A.Ali, F.Parker, T.Presti, R.M.O’Halloran, J.A.Thompson, R.M.Bäcker, M.Byrnes, K.Noor, A.Winokur, P.L.Meier, J.Stapleton, J.Mahgoub, S.M.Maxwell, C.Shami, S.Goepfert, P.A.Fusco, D.N.Drouin, A.C.Numbi, F.K.Lyke, K.E.Neuzil, K.M.Posavad, C.M.Meagher, M.A.McElrath, J.Gale, M.Stephens, D.S.Abebe, K.Albert, J.Telu, K.Mu, J.Makowski, M.Baughman, H.McQuarrie, L.Lewis, T.C.Giebeig, L.A.Engel, T.M.Griffith, C.J.McDonald, W.L.Burkey, A.E.Hoopengardner, L.B.Linton, J.E.Gettinger, N.L.Hill, H.Netzl, A.Wilks, S.H.Türeli, S.Smith, D.J.Makhene, M.Crandon, S.Nayak, S.U.Roberts, P.C.Beigel, J.H.Lee, M.Elsafy, M.Pikaart-Tautges, R.Arega, J.Hoang, B.Dan CurtinKoo, H.Sindall, E.DeGrace, M.M.Post, D.J.Stephens, D.S.Neuzil, K.M.Farley, M.M.Marrazzo, J.Young, S.P.Lennox, J.Atmar, R.L.McNeil, L.Brown, E.
Source
In: Nature Medicine. (Nature Medicine, September 2023, 29(9):2334-2346)
Subject
Language
English
ISSN
1546170X
10788956